October 2019 QSP SIG Newsletter
Download the October 2019 QSP SIG Newsletter here.
Regional QSP Day 2019
We are delighted to invite you to the first International Society of Pharmacometrics (ISoP) Regional Quantitative Systems Pharmacology (QSP) Day 2019, co-hosted by the ISoP QSP Special Interest Group (ISoP QSP SIG) and Bristol-Myers Squibb (BMS). The event is intended to highlight some of the recent achievements in QSP, illustrate application areas, and promote networking,…
NJ/PA ISoP Local Event
Please join us on Wednesday, April 17, 2019, at Social, 156 N Gaston Ave., Somerville, NJ 08876, for an evening of networking and socializing. This will be a casual event for local ISoP members and others in the pharmacometrics community to get together for networking, socializing, and planning for the groups upcoming events. This is…
ACoP 10
Planning for ACoP10 is underway! The Tenth American Conference on
Pharmacometrics (ACoP10) will be held October 20th to 23rd, 2019, at the Rosen Shingle Creek Hotel in Orlando, Florida.
Message From the President
2019 is going to be a pivotal year for ISoP. We have a number of significant changes coming down the road, the result of a lot of time and planning by our Board and our teams of volunteers. ISoP is growing from the equivalent of a plucky startup into a mature scientific society: by 2023…
A Conversation with Pharmacometrics Africa
Quantitative clinical pharmacology is well established in most parts of the world, but the low- and middle-income countries (LMIC’s) are underrepresented. To address this need, a team of pharmacologists have started a new organization known as Pharmacometrics Africa. I asked some of them to tell us more about their vision for the future: View full…
Papers Worth Reading
Choosing optimal doses to be used in clinical trials for potential new therapies is difficult as data can be limited. The ability to identify relevant doses is further complicated when the difference between concentrations that are efficacious and those causing toxicity are narrow. Add to these issues the need to not overshoot or undershoot a…